| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $350.4M | -3.4% |
| Cost of Revenue | $69.7M | +2.0% |
| Gross Profit | $280.7M | -4.6% |
| R&D Expense | $7.7M | -0.6% |
| SG&A Expense | $72.5M | -2.2% |
| Operating Income | $149.4M | +1.5% |
| Pre-tax Income | $122.2M | +18.5% |
| Income Tax | $32.8M | +26.8% |
| Net Income | $89.4M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $33.5M | -62.2% |
| Accounts Receivable | $24.9M | -5.4% |
| Current Assets | $74.5M | -40.5% |
| Total Assets | $602.2M | -7.0% |
| Current Liabilities | $79.3M | +11.1% |
| Long-term Debt | $593.0M | -19.2% |
| Total Liabilities | $681.7M | -17.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $121.7M | +6.7% |
| Capital Expenditures | $33.4M | -8.3% |
| Investing Cash Flow | -$33.4M | +17.4% |
| Financing Cash Flow | -$138.6M | -69.8% |
| Free Cash Flow | $88.3M | +13.7% |
| +15.7% |
| EPS (Basic) | $4.64 | +17.8% |
| EPS (Diluted) | $4.62 | +17.3% |
| Stockholders' Equity |
| -$79.5M |
| +54.9% |